Suppr超能文献

弓形虫钙依赖蛋白激酶 1 抑制剂:应用细胞热位移分析检测其活性和耐药性。

Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift Assays.

机构信息

Center for Infectious Disease Research, Seattle, Washington, USA.

Department of Medicine, Division of Allergy and Infectious Disease, Center for Emerging and Re-emerging Infectious Diseases (CERID), University of Washington, Seattle, Washington, USA.

出版信息

Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00051-18. Print 2018 Jun.

Abstract

In , calcium-dependent protein kinase 1 (CDPK1) is an essential protein kinase required for invasion of host cells. We have developed several hundred CDPK1 inhibitors, many of which block invasion. Inhibitors with similar 50% inhibitory concentrations (ICs) were tested in thermal shift assays for their ability to stabilize CDPK1 in cell lysates, in intact cells, or in purified form. Compounds that inhibited parasite growth stabilized CDPK1 in all assays. In contrast, two compounds that showed poor growth inhibition stabilized CDPK1 in lysates but not in cells. Thus, cellular exclusion could explain exceptions in the correlation between the action on the target and cellular activity. We used thermal shift assays to examine CDPK1 in two clones that were independently selected by growth in the CDPK1 inhibitor RM-1-132 and that had increased 50% effective concentrations (ECs) for the compound. The A and C clones had distinct point mutations in the CDPK1 kinase domain, H201Q and L96P, respectively, residues that lie near one another in the inactive isoform. Purified mutant proteins showed RM-1-132 ICs and thermal shifts similar to those shown by wild-type CDPK1. Reduced inhibitor stabilization (and a presumed reduced interaction) was observed only in cellular thermal shift assays. This highlights the utility of cellular thermal shift assays in demonstrating that resistance involves reduced on-target engagement (even if biochemical assays suggest otherwise). Indeed, similar ECs were observed upon overexpression of the mutant proteins, as in the corresponding drug-selected parasites, although high levels of CDPK1(H201Q) only modestly increased resistance compared to that achieved with high levels of wild-type enzyme.

摘要

在疟原虫中,钙依赖性蛋白激酶 1(CDPK1)是一种必需的蛋白激酶,对于入侵宿主细胞是必需的。我们已经开发了数百种 CDPK1 抑制剂,其中许多抑制剂可以阻断入侵。具有相似 50%抑制浓度(IC)的抑制剂在热转移测定中进行测试,以评估它们在细胞裂解物、完整细胞或纯化形式中稳定 CDPK1 的能力。抑制寄生虫生长的化合物在所有测定中均稳定 CDPK1。相比之下,两种表现出较差生长抑制的化合物在裂解物中稳定 CDPK1,但在细胞中不稳定。因此,细胞排除可以解释靶标作用与细胞活性之间相关性的例外情况。我们使用热转移测定法研究了两个通过在 CDPK1 抑制剂 RM-1-132 中生长独立选择的克隆中的 CDPK1,这两个克隆对该化合物的 50%有效浓度(EC)增加。A 和 C 克隆在 CDPK1 激酶结构域中分别具有独特的点突变,H201Q 和 L96P,这些残基在无活性同工型中彼此靠近。纯化的突变蛋白显示出与野生型 CDPK1 相似的 RM-1-132 IC 和热转移。仅在细胞热转移测定中观察到抑制剂稳定性降低(并且假定相互作用降低)。这突出了细胞热转移测定在证明耐药性涉及靶标结合减少(即使生化测定表明存在靶标结合)的有用性。事实上,正如在相应的药物选择寄生虫中观察到的那样,突变蛋白的过表达也观察到相似的 EC,尽管与高水平野生型酶相比,高水平的 CDPK1(H201Q)仅适度增加了耐药性。

相似文献

1
Toxoplasma Calcium-Dependent Protein Kinase 1 Inhibitors: Probing Activity and Resistance Using Cellular Thermal Shift Assays.
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00051-18. Print 2018 Jun.
4
Bumped kinase inhibitor 1294 treats established Toxoplasma gondii infection.
Antimicrob Agents Chemother. 2014 Jun;58(6):3547-9. doi: 10.1128/AAC.01823-13. Epub 2014 Mar 31.
5
In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum.
Antimicrob Agents Chemother. 2015 Oct;59(10):6361-74. doi: 10.1128/AAC.01236-15. Epub 2015 Jul 27.
6
Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy.
Int J Parasitol. 2016 Dec;46(13-14):871-880. doi: 10.1016/j.ijpara.2016.08.003. Epub 2016 Oct 8.
7
Identifying the Target of an Antiparasitic Compound in Using Thermal Proteome Profiling.
ACS Chem Biol. 2020 Jul 17;15(7):1801-1807. doi: 10.1021/acschembio.0c00369. Epub 2020 Jul 6.
9
Use of the kinase inhibitor analog 1NM-PP1 reveals a role for Toxoplasma gondii CDPK1 in the invasion step.
Eukaryot Cell. 2010 Apr;9(4):667-70. doi: 10.1128/EC.00351-09. Epub 2010 Feb 19.
10
Anticoccidial kinase inhibitors: identification of protein kinase targets secondary to cGMP-dependent protein kinase.
Mol Biochem Parasitol. 2006 Sep;149(1):86-98. doi: 10.1016/j.molbiopara.2006.05.003. Epub 2006 May 23.

引用本文的文献

3
Cloning, expression, and purification of an α-carbonic anhydrase from to unveil its kinetic parameters and anion inhibition profile.
J Enzyme Inhib Med Chem. 2024 Dec;39(1):2346523. doi: 10.1080/14756366.2024.2346523. Epub 2024 Jun 7.
4
Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of Cryptosporidiosis.
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0142522. doi: 10.1128/aac.01425-22. Epub 2023 Mar 15.
6
Protein kinases in Toxoplasma gondii.
Int J Parasitol. 2021 May;51(6):415-429. doi: 10.1016/j.ijpara.2020.11.006. Epub 2021 Feb 11.
7
Identifying the Target of an Antiparasitic Compound in Using Thermal Proteome Profiling.
ACS Chem Biol. 2020 Jul 17;15(7):1801-1807. doi: 10.1021/acschembio.0c00369. Epub 2020 Jul 6.
9
Bumped kinase inhibitor 1369 is effective against Cystoisospora suis in vivo and in vitro.
Int J Parasitol Drugs Drug Resist. 2019 Aug;10:9-19. doi: 10.1016/j.ijpddr.2019.03.004. Epub 2019 Apr 2.
10
Alterations in Phosphorylation of Hepatocyte Ribosomal Protein S6 Control Plasmodium Liver Stage Infection.
Cell Rep. 2019 Mar 19;26(12):3391-3399.e4. doi: 10.1016/j.celrep.2019.02.085.

本文引用的文献

2
Extended-spectrum antiprotozoal bumped kinase inhibitors: A review.
Exp Parasitol. 2017 Sep;180:71-83. doi: 10.1016/j.exppara.2017.01.001. Epub 2017 Jan 5.
3
Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy.
Int J Parasitol. 2016 Dec;46(13-14):871-880. doi: 10.1016/j.ijpara.2016.08.003. Epub 2016 Oct 8.
6
Bumped kinase inhibitor prohibits egression in Babesia bovis.
Vet Parasitol. 2016 Jan 15;215:22-8. doi: 10.1016/j.vetpar.2015.10.023. Epub 2015 Nov 5.
7
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of CDPK1.
ACS Med Chem Lett. 2015 Oct 22;6(12):1184-1189. doi: 10.1021/acsmedchemlett.5b00319. eCollection 2015 Dec 10.
8
Development of new highly potent imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1.
Eur J Med Chem. 2015 Nov 13;105:80-105. doi: 10.1016/j.ejmech.2015.10.004. Epub 2015 Oct 9.
9
A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.
PLoS One. 2015 Sep 22;10(9):e0138204. doi: 10.1371/journal.pone.0138204. eCollection 2015.
10
Calcium Signaling throughout the Toxoplasma gondii Lytic Cycle: A STUDY USING GENETICALLY ENCODED CALCIUM INDICATORS.
J Biol Chem. 2015 Nov 6;290(45):26914-26926. doi: 10.1074/jbc.M115.652511. Epub 2015 Sep 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验